The Bulletin
The Times


.

Zuellig Pharma Launches Lilly’s Innovative Obesity and Diabetes Medicine in Thailand

  • Written by The Bulletin

Mounjaro® (tirzepatide) will be available in the market from the end of May 2025

BANGKOK, THAILAND - Media OutReach Newswire - 27 May 2025 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounjaro® (tirzepatide), the innovative obesity and diabetes medicine developed by Eli Lilly and Company, will be launched in Thailand at the end of May 2025.

Read more: Zuellig Pharma Launches Lilly’s Innovative Obesity and Diabetes Medicine in Thailand

hacklink hack forum hacklink film izle hacklink Tuloskeskusjojobetjojobetcasibomjojobetesim balkancasibom girişgrandpashabet girişwww.jmctpolytechnic.orgbetparkbetparkonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline casinoonline pokieGalabetThe Pokies casinoplay pokies onlineonline pokiesbest pokies sitesThe Pokies reviewalykellomiehelle.comThe Pokies bonusRoyal reelsAustralian pokiesreal money pokiesz-libGalabetplay Royal ReelsRoyal Reels pokiesRoyal Reels pokiesRoyal Reels loginBoss Rummycasinos not on gamstopnon gamstop casinos ukcasinos not on gamstopnon gamstop casinocasinos not on gamstoponline gamblingbest casinos not on gamstopgambling sites not on gamstopgambling sites not on gamstopPadişahbetjojobetjojobetmatbetnakitbahisnakitbahismatbetjojobetholiganbetjojobet